Shem Patyna

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations

Medicine, Oncology, Pharmacology +11

Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells

Yvonne Will, James A. Dykens, Sashi Nadanaciva et al. · Toxicological Sciences · 2008 · 215 citations

Life Sciences, Oncology, Pharmacology +17

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Sandrine Faivre, Patricia Niccoli, Daniel Castellano et al. · Annals of Oncology · 2016 · 192 citations · Full text

Medicine, Oncology, Pharmacology +13

Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib

Carlo L. Bello, Marilyn Mulay, Xin Huang et al. · Clinical Cancer Research · 2009 · 103 citations

Medicine, Pharmacokinetics, Pharmacology +17

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Shem Patyna, Alexander Laird, Dirk B. Mendel et al. · Molecular Cancer Therapeutics · 2006 · 103 citations

Medicine, Oncology, Pharmacology +17